Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison

Recently, several drugs have been introduced for the first-line treatment of chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC), but few studies have compared treatment outcomes directly. This indirect comparison among 10 clinical trials (n = 4870 patients) retrieved from Pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Haofeng, Chen, Jialiang, Qiu, Wenhan, Lin, Sijie, Chen, Yanxiong, Liang, Guancan, Fang, Youqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989298/
https://www.ncbi.nlm.nih.gov/pubmed/29951524
http://dx.doi.org/10.1155/2017/3941217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989298/
https://www.ncbi.nlm.nih.gov/pubmed/29951524
http://dx.doi.org/10.1155/2017/3941217

Ejemplares similares